A Narrative Review of Aspirin Resistance in VTE Prophylaxis for Orthopaedic Surgery

  title={A Narrative Review of Aspirin Resistance in VTE Prophylaxis for Orthopaedic Surgery},
  author={Nameer van Oosterom and Michael A. Barras and Robert J Bird and Iulian Nusem and Neil Cottrell},
  pages={1889 - 1899}
Total hip arthroplasties (THA) and total knee arthroplasties (TKA) confer one of the highest risks for developing venous thromboembolism (VTE) and pharmacological prophylaxis is imperative to help mitigate the risks. Aspirin is the most cost-effective medication for VTE prophylaxis, and its use post-THA/TKA has grown in popularity. Aspirin resistance is categorised as clinical or laboratory resistance with obesity, advancing age, diabetes mellitus, dyslipidaemia and inflammatory diseases… 
Asia-Pacific venous thromboembolism consensus in knee and hip arthroplasty and hip fracture surgery: Part 1. Diagnosis and risk factors
An AP consensus agreement on VTE prophylaxis in knee and hip arthroplasty and hip fracture surgery in Asian patients among AP orthopedic experts is obtained in a one-year period to provide Orthopedic surgeons who practice in the AP Region appropriate options for VTE diagnosis and prevention methods that benefit their patients with fewer complications.
Platelet Function Assays for the Diagnosis of Aspirin Resistance
Comparison of the most frequently used platelet assays to diagnose aspirin resistance, including the basic mechanism, methodology, reference ranges, inter-assay comparison, and their respective clinical considerations when using are compared.
Assessment of Risk Factors for Drug Resistance of Dual Anti Platelet Therapy After PCI
  • Lijie Zhang, Ying Lv, S. Jiang
  • Biology
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
  • 2022
Aspirin resistance was found to usually accompany clopidogrel resistance, and 99 patients showed dual antiplatelet drug resistance, for which platelet count and monocyte count were the risk factors.
Performance comparison of aspirin assay between Anysis and VerifyNow: Assessment of therapeutic platelet inhibition in patients with cardiac diseases
Anysis-aspirin, a novel aspirin assay for assessing platelet inhibition, showed excellent agreement with VerifyNow- aspirin with high accuracy and precision and would be used as a point-of-care test to assess aspirin non-responsiveness and abnormal platelet reactivity.


Thromboembolism prophylaxis in orthopaedics: an update
It is suggested that LMWH seems to be more efficient overall compared with the other available agents, while sceptical about the use of aspirin as a sole method of prophylaxis in total hip and knee replacement and hip fracture surgery.
Safety and effectiveness of aspirin and enoxaparin for venous thromboembolism prophylaxis after total hip and knee arthroplasty: a systematic review
The risks and benefits of aspirin compared to enoxaparin as VTE prophylaxis for patients undergoing THA or TKA are assessed.
Preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty.
  • Michael A Mont, J. Jacobs, Patrick Sluka
  • Medicine
    The Journal of the American Academy of Orthopaedic Surgeons
  • 2011
Early mobilization for patients following elective hip and knee arthroplasty is recommended and no clear evidence was established regarding whether inferior vena cava filters can prevent pulmonary embolism in patients who have a contraindication to chemoprophylaxis and/or known VTED.
Aspirin Versus Low-Molecular-Weight Heparin for Extended Venous Thromboembolism Prophylaxis After Total Hip Arthroplasty
Extended prophylaxis for 28 days with aspirin was noninferior to and as safe as dalteparin for the prevention of VTE after THA in patients who initially received daltEParin for 10 days.
Impact of venous thromboembolism on clinical management and therapy after hip and knee arthroplasty.
  • W. Fisher
  • Medicine
    Canadian journal of surgery. Journal canadien de chirurgie
  • 2011
The introduction of new oral agents (e.g., dabigatran etexilate and rivaroxaban) may facilitate guideline adherence, particularly in the outpatient setting, owing to their oral administration without the need for routine coagulation monitoring.
Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty
Extended prophylaxis with aspirin was not significantly different from rivaroxaban in the prevention of symptomatic venous thromboembolism after total hip or total knee arthroplasty.
Narrative Review: Aspirin Resistance and Its Clinical Implications
This paper reviews the concept of aspirin resistance, its measurement, and its clinical consequences for patients prescribed aspirin and outlines some of aspirin's clinical effects in cardiovascular disease.
A Systematic Review on the Use of Aspirin in the Prevention of Deep Vein Thrombosis in Major Elective Lower Limb Orthopedic Surgery: An Update from the Past 3 Years
Aspirin is an effective and safe prophylactic against deep vein thrombosis following major elective lower limb arthroplasty surgery, based on literature of the past 3 years.
Venous Thromboembolism Prophylaxis After TKA: Aspirin, Warfarin, Enoxaparin, or Factor Xa Inhibitors?
Factor Xa inhibitors had the highest growth in utilization during the study period, followed by aspirin, when compared with enoxaparin and warfarin, and factor Xa inhibitor provided improved VTE prophylaxis when selected for the right patient.